Back to Search
Start Over
The controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review
- Publication Year :
- 2020
-
Abstract
- Introduction: Meningiomas represent the most common primary intracranial tumors. Today, surgical resection, followed by radiotherapy when indicated, is still the treatment of choice. In recent year...
- Subjects :
- 0301 basic medicine
Surgical resection
medicine.medical_specialty
Bevacizumab
medicine.medical_treatment
Angiogenesis Inhibitors
NO
Meningioma
03 medical and health sciences
0302 clinical medicine
medicine
Meningeal Neoplasms
Humans
Pharmacology (medical)
Molecular Targeted Therapy
Personalized therapy
personalized therapy
business.industry
Brain Neoplasms
targeted inhibitors
medicine.disease
Radiation therapy
Survival Rate
030104 developmental biology
Oncology
Bevacizumab, immunotherapy, meningioma, personalized therapy, targeted inhibitors, Angiogenesis Inhibitors, Brain Neoplasms, Molecular Targeted Therapy, Meningioma, Survival Rate
030220 oncology & carcinogenesis
Radiology
immunotherapy
Intracranial meningioma
business
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2a2a073255cfa76719cf7b91a378514e